• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗纤维蛋白溶解疗法对蛛网膜下腔出血后脑血管痉挛和脑积水影响的实验研究

An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.

作者信息

Kenning J A, Heros R C, Dujovny M, Latchaw R E, Nelson D

出版信息

Surg Neurol. 1984 Feb;21(2):159-64. doi: 10.1016/0090-3019(84)90335-5.

DOI:10.1016/0090-3019(84)90335-5
PMID:6701753
Abstract

The incidence and severity of cerebral vasospasm and hydrocephalus following induced subarachnoid hemorrhage in an experimental group of animals that subsequently received epsilon-aminocaproic acid was compared to that seen in a control group that received no antifibrinolytic therapy. No augmentation of either vasospasm or hydrocephalus could be attributed to the epsilon-aminocaproic acid in the treated as compared to the control group.

摘要

将随后接受ε-氨基己酸治疗的实验组动物诱导性蛛网膜下腔出血后脑血管痉挛和脑积水的发生率及严重程度,与未接受抗纤维蛋白溶解治疗的对照组进行比较。与对照组相比,治疗组中无论是脑血管痉挛还是脑积水,均未发现可归因于ε-氨基己酸的增加情况。

相似文献

1
An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.抗纤维蛋白溶解疗法对蛛网膜下腔出血后脑血管痉挛和脑积水影响的实验研究
Surg Neurol. 1984 Feb;21(2):159-64. doi: 10.1016/0090-3019(84)90335-5.
2
Medical management of patients following a ruptured cerebral aneurysm, with epsilon-aminocaproic acid, kanamycin, and reserpine.使用ε-氨基己酸、卡那霉素和利血平对脑动脉瘤破裂患者进行药物治疗。
Surg Neurol. 1982 Mar;17(3):181-5. doi: 10.1016/0090-3019(82)90271-3.
3
Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.ε-氨基己酸与复发性蛛网膜下腔出血:一项临床试验
J Neurosurg. 1980 Jul;53(1):28-31. doi: 10.3171/jns.1980.53.1.0028.
4
Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.抗纤维蛋白溶解疗法治疗动脉瘤性蛛网膜下腔出血患者的现状
Stroke. 1982 Mar-Apr;13(2):256-9. doi: 10.1161/01.str.13.2.256.
5
Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.颅内动脉瘤与蛛网膜下腔出血。一项合作研究。近期发生的蛛网膜下腔出血的抗纤溶治疗。
Stroke. 1975 Nov-Dec;6(6):622-9. doi: 10.1161/01.str.6.6.622.
6
Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.颅内动脉瘤破裂所致蛛网膜下腔出血的抗纤溶治疗
Neurology. 1981 Mar;31(3):316-22. doi: 10.1212/wnl.31.3.316.
7
Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor.
Surg Neurol. 1979 Jan;11(1):73-80.
8
Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms.颅内动脉瘤破裂导致蛛网膜下腔出血后的脑积水和血管痉挛。
Neurosurgery. 1986 Jan;18(1):12-6. doi: 10.1227/00006123-198601000-00003.
9
Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm.蛛网膜下腔出血后患者循环血容量降低:对症状性血管痉挛管理的影响
Neurosurgery. 1984 Sep;15(3):354-61. doi: 10.1227/00006123-198409000-00010.
10
Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.在早期动脉瘤手术前降低再出血风险:抗纤溶治疗的潜在作用。
J Neurosurg. 1997 Feb;86(2):220-5. doi: 10.3171/jns.1997.86.2.0220.

引用本文的文献

1
Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.抗纤维蛋白溶解疗法预防蛛网膜下腔出血后早期再出血
Neurocrit Care. 2008;8(3):418-26. doi: 10.1007/s12028-008-9088-5.